bioMérieux, a world leader in the field of in vitro diagnostics, today announced that its subsidiary, BioFire Defense, has received Emergency Use Authorization by the U.S. Food and Drug Administration of its BIOFIRE COVID-19 test for use in CLIA moderate and high complexity clinical laboratories to detect SARS-CoV-2.

We’ve been fairly quiet about COVID here, largely because any reporting is quickly over taken by events. Scientific advice has remained fairly consistent, but how that is applied nationally and the impact of rising rates of infection is hugely variable.

A Belarusian man has been indicted on charges of mailing packages containing a poisonous substance to a California state prison. 

14 people have died, and 500 have reported being sickened in the southern port city of Karachi, in an incident involving a substance yet to be identified by authorities. 

Convergence 2020 is being held in the beautiful Boston, and is sure to be one not to be missed! Head over to the event pages and register your place now.